Many bioactive peptides terminate with an amino acid a-amide at their COOH terminus. The enzyme responsible for this essential posttranslational modification is known as peptidyl-glycine a-amidating monooxygenase or PAM. We identified cDNAs encoding the enzyme by using antibodies to screen a bovine intermediate pituitary \gt11 expression library. Antibodies to a /?-galactosidase/PAM fusion protein removed PAM activity from bovine pituitary homogenates. The 108,207 dalton protein predicted by the complete cDNA is approximately twice the size of purified PAM. An NH 2 -terminal signal sequence and short propeptide precede the NH 2 terminus of purified PAM. The sequences of several PAM cyanogen bromide peptides were localized in the NH 2 -terminal half of the predicted protein. The cDNA encodes an additional 430 amino acid intragranular domain followed by a putative membrane spanning domain and a hydrophilic cytoplasmic domain. The forms of PAM purified from bovine neurointermediate pituitary may be generated by endoproteolytic cleavage at a subset of the 10 pairs of basic amino acids in the precursor. High levels of PAM mRNA were found in bovine pituitary and cerebral cortex. In corticotropic tumor cells, levels of PAM mRNA and pro-ACTH/endorphin mRNA were regulated in parallel by glucocorticoids and CRF. (Molecular Endocrinology 1: 777-790, 1987) 
INTRODUCTION
Although the importance of posttranslational processing of precursors to bioactive peptides is well known, 0888-8809/87/0777-0790$02.00/0 Molecular Endocrinology Copyright © 1987 by The Endocrine Society very little is known about the many enzymes involved in converting inactive precursors into bioactive products. We have focused our studies on the a-amidation of bioactive peptides (1) (2) (3) . Approximately half of the known neuronal and endocrine peptides (e.g. gastrin, neuropeptide Y, vasopressin, CRF) have an a-amidated amino acid at their COOH terminus and the presence of this a-amide moiety is generally essential for biological activity. Alpha-amidation appears to be uniquely associated with bioactive peptides; a number of novel bioactive peptides have been identified based solely on the fact that they terminate with an amino acid a-amide (4, 5) .
Prohormone sequences consistently contain a -Gly residue to the COOH-terminal side of the residue aamidated in the product peptide. Using a synthetic peptide, D-Try-Val-Gly, Bradbury et a/. (6) (7) (8) identified a-amidation activity in porcine pituitary extracts; reaction products included D-Tyr-Val-NH 2 , with the amide nitrogen derived from the amino group of Gly and glyoxylate. Although the amidation reaction requires a peptide substrate with a COOH-terminal glycine, it is capable of producing peptides terminating with a wide variety of amino acid a-amides.
Requirements for amidation activity in a number of different tissues are very similar (1) (2) (3) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . The enzyme purified from bovine neurointermediate pituitary requires the presence of molecular oxygen, catalyzes the consumption of ascorbic acid, and is inhibited by the addition of divalent metal ion chelators; activity is restored by the addition of CuSO 4 (1 -3) . The enzyme has therefore been referred to as peptidyl-glycine aamidating monooxygenase or PAM. Dopamine /3-hydroxylase, a key enzyme in the synthesis of catecholamines, exhibits similar requirements. Two forms of PAM were purified from bovine neurointermediate pituitary: PAM-A, mol wt 54,000 and PAM-B, mol wt 39,000. Sequence analysis and peptide mapping indi-cated that the two were closely related. PAM is localized to secretory granules and is cosecreted with pro-ACTH/endorphin-related peptides from corticotropic tumor cells in response to CRF or cAMP (13, 14) . Levels of PAM activity are regulated in parallel with levels of prohormone in corticotropes and melanotropes (15) .
RESULTS AND DISCUSSION

Identification of cDNAs Encoding PAM
PAM purified from bovine neurointermediate pituitary was used to generate rabbit polyclonal antisera. When cross-linked to Protein A-Sepharose resin, PAM antiserum 36 removed equivalent amounts of PAM activity and 125 l-labeled PAM protein from solution (16) , consistent with the identity of the enzyme and the major protein. Purified PAM was linked to activated CH-Sepharose and used to prepare affinity purified PAM antiserum for screening of a bovine intermediate pituitary Xgt11 expression library.
Purified PAM-B was used for NH 2 -terminal amino acid sequence determination (Table 1) . Since there were ambiguities at a number of positions in the NH 2 -terminal sequence, data were obtained for a series of cyanogen bromide fragments of PAM-A and PAM-B (Table 1 ). The reduced and alkylated cyanogen bromide fragments were fractionated by gel filtration; fractions containing cyanogen bromide peptides ranging in size from 12,000 to 2000 daltons were further purified by reverse phase-HPLC. The amino acid sequences obtained for five cyanogen bromide peptides showed no significant homology to amino acid sequences in the National Biomedical Research Foundation Protein Sequence Database. Oligonucleotides corresponding to three sepa-rate regions of sequence were synthesized (Table 1) .
A bovine intermediate pituitary Xgt11 cDNA library was prepared from 5 ng poly(A) + RNA. Complementary DNAs of greater than 500 base pairs (bp) were selected and a total of 2.3 x 10 6 recombinant phage were obtained. When screened with the nick translated cDNA for pro-ACTH/endorphin, approximately 14% of the recombinant phage were positive, as expected for this tissue. Upon screening 360,000 recombinant phage with affinity purified PAM antibody 36, four positive phage were identified and plaque purified. Phage XPAM-1 contained the largest insert and the EcoRI fragments generated from XPAM-1 [0.4-kilobase (kb), 0.7-kb, and 2.2-kb fragments] were subcloned, nick translated, and used to probe Southern blots of EcoRI digests of the other XPAM phage (16) ; the phage were found to represent overlapping clones ( Fig. 1 A) .
The fusion proteins produced by XPAM-1, -3, and -5 were quite similar in size ( Fig. 2) , despite the fact that the 2.2-kb fragment of XPAM-1 cross-hybridized with much smaller (1.4 kb) EcoRI fragments from XPAM-3 and -5. The fusion protein produced by XPAM-2 was slightly smaller than the fusion protein produced by XPAM-1, -3, or -5, suggesting that the regions missing in XPAM-2 were protein coding and that the 5'-to 3'orientation of the EcoRI fragments was as shown in Fig. 1 . The fact that oligonucleotides 6 and 8 crosshydridized with the 0.7 kb EcoRI fragments of XPAM-1, -3, and -5, but not with XPAM-2, -3A, or -5A also indicated that the portion of the 0.7-kb fragment adjacent to the 0.4-kb fragment was a protein-coding region.
The EcoRI fragments of XPAM-1 and XPAM-5 were subcloned and sequenced by the dideoxy chain termination method (18) (19) (20) using the strategies outlined in Fig. 1B . Although XPAM-1 contained the poly(A) tail, partial sequence analysis demonstrated that the corn- Fig. 1 . XPAM Clones Obtained by Screening cDNA Library with PAM Antibodies A, Four phage identified with affinity purified PAM antiserum 36 were plaque purified from the Xgt11 bovine intermediate pituitary cDNA library. Phage DNA was digested with EcoRI and the sizes of the fragments released were determined by agarose gel electrophoresis. The EcoRI fragments of XPAM-1 were subcloned into Bluescript (Stratagene), nick translated, and used to probe Southern blots of EcoRI digests of the other phage. The fragments were initially placed in 5'-to 3'-order based on the molecular weight of the fusion proteins produced in E. coli strain CAG456 cells and on the ability of synthetic oligonucleotides (Table 1) to hybridize with the restriction fragments. Phage XPAM-3A and -5A arose during the plaque purification of XPAM-3 and -5. B, The sequencing strategies used for XPAM-1, -5, and -6 are indicated. The relationship of the cyanogen bromide peptides sequenced and the synthetic oligonucleotides to the cDNA are indicated. 
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Fig. 2. Production of Fusion Protein by XPAM Clones
Ten-milliliter cultures of E. coli strain CAG456 cells were infected with wild type Xgt11 (WT), XPAM-1 (P-1), XPAM-2 (P-2), or XPAM-3 (P-3), and induced with 10 mM isopropyl-/3-D-thiogalactopyranoside; after 2 h at 37 C cells were pelleted and dissolved in boiling SDS-gel sample buffer (17) containing 0.3 mg/ml phenylmethylsulfonylfluoride. Uninfected CAG456 cells served as the control (CON). Aliquots equivalent to 5% of the sample were fractionated by gel electrophoresis on 8% polyacrylamide, 0.2% N, A/'-methylenebisacrylamide slab gels (17) , transferred to nitrocellulose, and visualized with PAM antibody 36 (P) or a mouse monoclonal antibody to /3-galactosidase (G) (Promega, Madison, Wl) and 125 l-labeled Protein A. The visualization procedure was identical to that described for screening the Xgt11 library. Location of molecular weight markers is indicated. hybridizing with the 0.4-kb fragment of XPAM-1 (from XPAM-6, Fig. 1B ) was subcloned and sequenced and found to encode the NH 2 terminus of the protein. The bovine intermediate pituitary library contained approximately 2500 times as many copies of pro-ACTH/endorphin cDNA as PAM cDNA, in good agreement with previous estimates based on protein and peptide purification (1, 2) .
Characterization of Fusion Protein
The molecular weights of the fusion proteins (21, 22) produced by bacteria infected with XPAM-1, 2 and 3 were determined. Extracts of infected bacteria were fractionated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and visualized with antibody to /3-galactosidase or PAM (Fig. 2 ). Although the fusion proteins produced were clearly heterogeneous, the largest protein recognized by the PAM antibody had a molecular weight slightly greater than that of myosin, indicating that a fusion protein with a PAM-related region of approximately 100,000 daltons was being synthesized. PAM purified from bovine neurointermediate pituitary is only half this size (1, 2) . Upon lysis with a buffer containing Na TES and NaCI, the fusion protein remained insoluble. Attempts to solubilize the fusion protein by extraction of the pellet with buffer containing 1 % NP-40, Triton X-100, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, or Tween-20 were unsuccessful. Time course studies demonstrated the same heterogeneous collection of fusion proteins when incubation times were as short as 1 h.
In order to verify that the cloned cDNA did indeed encode the enzyme PAM, XPAM-1 encoded fusion proteins were partially purified by gel filtration in the presence of SDS and used to generate antibodies. The same major band was seen when Western blots of bovine neurointermediate pituitary were visualized with the fusion protein antibody or with PAM antibody 36. Fusion protein antibodies were linked to Protein A Sepharose resin and assayed for their ability to bind PAM enzyme activity from preparations of purified PAM and from bovine pituitary homogenates ( Table 2) . One of the fusion protein antibodies obtained bound enzyme activity from preparations of PAM-A, PAM-B, and crude bovine neurointermediate pituitary homogenate. The fact that antibodies to fusion protein recognize bovine pituitary PAM activity demonstrates that the cDNAs obtained do encode an a-amidation enzyme.
Sequence of PAM cDNA
The nucleotide sequences of XPAM-1, -5, and -6 were assembled to form a 3724 bp cDNA ( Fig. 3) . A single potential initiator (23) Met occurs at position 134 and is preceded by a GC rich (84% G+C) 5'-nontranslated region and followed by a putative signal sequence; the only other Met codon in this region (position 67) is followed immediately by a stop codon. The nucleotide sequences of the two 0.7-kb fragments examined were identical except for a single base difference at position 954, resulting in substitution of an Arg (XPAM-5) for a His as shown for XPAM-1. The sequences of all five cyanogen bromide fragments of PAM were contained within the 0.8-and 0.7-kb fragments. The sequence of the 1.4-kb fragment of XPAM-5 was contained within that of the 2.2-kb fragment of XPAM-1 except for the presence of a 54 bp insertion in the 2.2-kb fragment of XPAM-1 (positions 2823-2876). The 54 bp insertion in XPAM-1 encodes an 18 amino acid peptide and may represent use of alternate acceptor sites in the splicing of an intron; the nucleotide sequence in this region is compatible with the occurrence of alternate splicing (24) . The cDNAs sequenced contain open reading frames encoding 972 or 954 amino acids (proteins of 108,207 daltons or 106,195 daltons, respectively). The 675 bp 3'-nontranslated region contains multiple stop codons in all three reading frames and is relatively AT rich (62% A+T). The poly(A) tail in XPAM-1 is preceded by a consensus poly(A) addition site (AATAAA) 16 bp before the poly(A) tail (25, 26) . No homologous repeated sequences were found in XPAM-1 using either the nucleotide or amino acid sequence. No significant homologies were found to sequences in the GenBank (Update 48), European Molecular Biology Laboratories, or National Biomedical Research Foundation databases.
Structure of PAM Precursor
The key features of the proteins encoded by these cDNAs are summarized in Fig. 4 . The single potential initiator Met is followed immediately by a hydrophobic Aliquots of PAM-A (0.95 pmol/h), PAM-B (0.65 pmol/h), or 100,000 x g bovine neurointermediate pituitary supernatant (2.78 pmol/ h) were incubated with Protein A-Sepharose resin to which immunoglobulins from the antisera indicated had been covalently crosslinked (16) . Aliquots (100 »\ 1:10 slurry) of the antibody resins were tested. PAM activity bound to the resin was assayed in duplicate; duplicates varied less than ±15%. This experiment was repeated nine times in various forms with similar results, looking at depletion of PAM activity from the supernatant or appearance of PAM activity bound to the resin. The nucleotide sequences obtained for XPAM-1, -5, and -6 have been used to construct the cDNA sequence and to predict the amino acid sequence. The entire molecule was sequenced on both strands of the DNA, as diagramed in Fig. 1B . The amino acid sequence is numbered below the line from the initiator Met (marked by a large downward arrow). Amino acid residues underlined coincide with peptide sequence information obtained from cyanogen bromide fragments ( Table 1) . Pairs of basic amino acids are marked by a pair of dark triangles. Potential sites for N-linked glycosylation are indicated with dots. The poly(A) addition signal is boxed. In XPAM-5, position 954 is G, resulting in substitution of Arg for His; in addition, in XPAM-5, the 54-bp segment from nucleotide 2823-2876 (shown in brackets) is absent. segment characteristic of a signal sequence (27) (28) (29) . Based on all of the accepted criteria (27) (28) (29) , the only likely site for signal peptide cleavage is between Gly 20 and Phe 21 ; until the exact site has been experimentally determined, the amino acid sequence has been numbered with the initiator Met as position 1.
Protein sequence information from intact PAM-B and from two cyanogen bromide peptides (Table 1 ; demonstrated two populations of molecules differing in length at the NH 2 -terminus. One could be attributed to endoproteolytic cleavage after Lys 29 Arg 30 , and another after Arg 36 ; the cleavage after Arg 36 appeared slightly predominant, constituting approximately 60% of the total. This heterogeneity could have arisen, at least in part, from the use of frozen bovine pituitaries as the source of the protein purified for sequence analysis. The short segment between Phe 21 and the NH 2 -terminal residues appears to represent a "pro-peptide" removed after cleavage of the signal sequence. It is not yet clear whether the presence of this pro-peptide affects enzymatic activity. Ten pairs of basic amino acids occur in the protein. Generation of the COOH termini of PAM-A and PAM-B could result from endoproteolytic cleavage at pairs of basic amino acids (Fig. 4) . PAM-B could be produced by cleavage at Lys 378 -Arg 379 (producing a 347 amino acid protein with a mol wt of 38,934) and PAM-A by cleavage at Lys 432 -Lys 433 (producing a 401 amino acid protein with mol wt of 45,046). In this scheme the peptide segment present in PAM-A and absent from PAM-B is acidic (calculated pi = 4.6) and would account for the fact that PAM-A binds to diethylaminoethylcellulose at neutral pH while PAM-B does not (2) . Two clusters of His residues occur in the part of the protein encoding the active enzyme ( Fig. 4) and may be involved in the interaction of the enzyme with copper (30) . This region contains one of the two potential sites for N-linked glycosylation (Asn^-Pro-Thr 413 ); however, the presence of a Pro between the Asn and Thr makes glycosylation at this site unlikely (31) . Consistent with this structure bovine PAM-B does not bind to lectin affinity resins (2) .
The open reading frame continues for another 430 residues after the putative COOH terminus of PAM-A before reaching an extremely hydrophobic 24 amino acid segment that very likely constitutes a transmembrane domain (amino acid residues 864-887). Two pairs of basic amino acids occur in the protein segment between the COOH terminus of PAM-A and the putative transmembrane domain; this segment of the protein would be exposed to the intragranular milieu and these sites could constitute endoproteolytic processing sites. Since this region of the protein has never been examined, it is not known whether the remaining potential site for N-linked glycosylation (Asn 762 -Phe-Ser 764 ) is used.
The calculated hydrophobicity index for the putative transmembrane segment is 2.9; any peptide segment of this length with a hydrophobicity index of greater than 1.6 is highly likely to be membrane-spanning (32, 33) . Immediately after the putative transmembrane domain is a cluster of basic amino acids (-Arg 888 -Trp-Lys-Lys-Ser-Arg 893 ). Such clusters of basic amino acids are characteristic of the cytoplasmic side of membrane spanning domains and are believed to serve as a stop transfer signal (32, 33) . If the hydrophobic segment does serve as a transmembrane domain, the remaining COOH-terminal region of the protein (residues 888 to 972) would be positioned in the cytoplasm. Preliminary studies have demonstrated the presence of substantial amounts of membrane-associated PAM activity in mouse corticotrope tumor cells and rat anterior pituitary, with lesser amounts of membrane associated PAM activity in rat neurointermediate pituitary (May, Victor, personal communication).
The COOH-terminal domain contains three or four pairs of basic amino acids and has a very unusual amino acid composition. In XPAM-1 the open reading frame after the putative transmembrane domain encodes a total of 85 amino acids before reaching an in frame stop codon (3050); in XPAM-5 this region is 67 amino acids long. The 54 bp insertion that distinguishes XPAM-1 and XPAM-5 occurs immediately after the putative transmembrane domain and encodes an 18 amino acid segment containing one of the pairs of basic amino acids (Fig. 4) . The COOH-terminal domain of both proteins is very rich in charged amino acids (19% Lys or Arg, 17% Asp or Glu for XPAM-1) and in Ser or Thr (16%), and Gly or Pro (20%). Based on the substrate specificity of cyclic nucleotide-dependent protein kinases, Ca ++ -calmodulin-dependent protein kinase, and protein kinase C, the COOH-terminal domain contains several potential phosphorylation sites (Ser 892934942 ) (34) (35) (36) (37) (38) .
Northern Blot Analysis of PAM mRNA
In order to determine the approximate size of the mRNA encoding PAM and its tissue localization, total RNA from a variety of bovine tissues was fractionated on denaturing agarose gels, transferred to Nytran, and hybridized with probes prepared from the 0.7-kb and 2.2-kb fragments of XPAM-1 (Fig. 5 ). The highest levels of PAM mRNA were found in the neurointermediate lobe of the pituitary and in the cerebral cortex; lower levels were found in the anterior pituitary and none was detectable in the liver. Levels of PAM mRNA in bovine hypothalamus were similar to those in cerebral cortex; levels in cerebellum were below the limit of detection. Some evidence of size heterogeneity was observed, with the major mRNA species being approximately 3.7 kb. Both cDNA probes hybridized with mRNA species of similar size in rat pituitary and brain and in mouse AtT-20 cells.
Previous studies had demonstrated that levels of PAM enzyme activity in AtT-20 corticotropic tumor cells were down-regulated by glucocorticoids in parallel with levels of immunoactive hormone (14) . In order to determine whether this parallel regulation of prohormone and processing enzyme reflected parallel regulation at the level of mRNA, AtT-20 cells were treated with the synthetic glucocorticoid dexamethasone or the secretagogue CRF; total RNA was fractionated on denaturing agarose gels and analyzed with PAM cDNA and pro-ACTH/endorphin cDNA (Fig. 6 ). Levels of PAM mRNA and pro-ACTH/endorphin mRNA were both diminished approximately 2-fold by pretreatment with dexamethasone and stimulated approximately 2-fold by application of CRF. Thus the parallel regulation of hormone and PAM enzyme activity observed previously can be accounted for by parallel alterations in the levels of the two mRNAs.
CONCLUSIONS
PAM represents the first posttranslational processing enzyme whose structure has been fully elucidated. Studies of regulatory processes affecting neuronal and endocrine cells producing a-amidated peptides can now be expanded to include effects on a processing enzyme as well as effects on synthesis and secretion of the peptides themselves. At least in corticotropes, levels of PAM mRNA are subject to regulation by secretagogues. Since it can be estimated that a granule contains only a few molecules of PAM, regulation of PAM , the precursor to PAM contains many pairs of basic amino acids; endoproteolytic processing may play a role in the tissue-specific maturation of posttranslational processing enzymes as well as their peptide substrates. The presence of a membrane-spanning domain in the COOH-terminal region of the precursor to PAM could allow expression of functional enzyme on the cell surface. The hydroxyl-rich hydrophilic cytoplasmic domain with several potential phosphorylation sites is similar to the COOH-terminal cytoplasmic domains of rhodopsin and the /3-adrenergic receptor (38) . The fact that precursors to a series of growth factors related to EGF have COOH terminally located membrane spanning domains and can be expressed on the cell surface (40, 41) raises the intriguing possibility that enzymes traditionally regarded as functioning within secretory granules may also play a role in cell surfacemediated interactions.
PAE
Fig. 6. Parallel Regulation of PAM and pro-ACTH/Endorphin mRNAs in Corticotropic Tumor Cells
AtT-20 cells were grown in regular growth medium or pretreated in medium containing 1 /UM dexamethasone for 72 h. Cells were then exposed for 5 h to CQntrol medium or medium with 1 UM dexamethasone or 100 nM CRF. Secretory rates in the various treatments (percent cell hormone content secreted per hour) were as follows: control, 3.5; CRF, 9.9; dexamethasone, 2.0. Total RNA (10 Mg/'ane) was analyzed as in Fig. 5 and probed with the 0.7-kb fragment of XPAM-1 (1.0 x 10 9 cpm/^g) and with the pro-ACTH/endorphin cDNA probe (0.2 x 10 9 cpm//xg) with the amounts of the two probes adjusted to give comparable intensities for the pro-ACTH/endorphin and PAM mRNAs. Similar results were obtained in two other experiments.
expression may regulate production of bioactive «amidated peptides. The structure of the predicted precursor to PAM has important implications for the role of this enzyme. Like the precursor to another granuleassociated peptide-processing enzyme, carboxypeptid-
MATERIALS AND METHODS
Sequence Analysis of PAM Peptides
PAM was purified from 400 bovine neurointermediate pituitaries as described (2) . Fractions containing purified PAM-B (typically 20 to 70 ng) were dried under vacuum and dissolved in 0.2 ml 70% formic acid for cleavage with cyanogen bromide. Cyanogen bromide (10 mg) was added and the samples were incubated at room temperature for 12 h in the dark; a second addition of cyanogen bromide (4 mg) was made and the peptides were dried under vacuum after 12 h. Peptides were dissolved in 100 iA 0.5 M Tris HCI, pH 8.5, 6 M guanidine HCI, 10 mM dithiothreitol, and incubated at 37 C for 2 h; samples were chilled, made 20 mM in iodoacetamide, and incubated 2 h on ice in the dark. In some analyses, the cyanogen bromide fragments were alkylated first with 10 mM [2-3 H]iodoacetic acid (Amersham, Arlington Heights, IL; 144 mCi/mmol) for 2 h followed by reaction with 10 mM unlabeled iodoacetic acid for 1 h. After reduction and alkylation, the peptides were fractionated on a column of Sephadex G-50 Superfine (38 x 1 cm), equilibrated and eluted with 10% formic acid. The size fractionated cyanogen bromide peptides were pooled, dried under vacuum, and purified on a ^Bondapak C18 column (7.5 x 300 mm; Waters Associates, Bedford, MA) equilibrated with 0.1% trifluoroacetic acid and eluted with a series of linear gradients to 80% acetonitrile in 0.1% trifluoroacetic acid. Peptides were detected by absorbance at 220 nm. Edman degradations were carried out using the Applied Biosystems (Foster City, CA) model 470A/120A gas phase sequencer (42, 43) . To calibrate recoveries, an aliquot was hydrolyzed in 6 N HCI (24 h, 110 C) and subjected to amino acid analysis on the Beckman (Fullerton, CA) model 6300 analyzer. Oligonucleotide probes corresponding to preliminary sequences of three cyanogen bromide peptides were synthesized on a BioSearch (San Rafael, CA) model 8600 DNA synthesizer using the criteria of Lathe (44) to select codons.
Construction and Screening of cDNA Libraries
PAM antiserum 36 was generated by subcutaneous injection of a rabbit with 9 ^g PAM-B (2) dissolved in 0.9% NaCI, 0.75% SDS by boiling, and emulsified with complete Freund's adjuvant; the rabbit was boosted once with a similar sample of PAM-B and twice with a mixture of PAM-A plus PAM-B. For affinity purification, the protein in a pool of purified PAM-A plus PAM-B from 400 bovine neurointermediate pituitaries was linked to 350 mg activated CH-Sepharose 4B (Pharmacia, Piscataway, NJ). Antiserum was affinity purified as described (45) . The basic procedures of Snyder et at. (21) were followed in preparing and screening the cDNA library. Total RNA was prepared from bovine intermediate pituitaries (46) ; 5 ng poly(A) + RNA were used for synthesis of cDNA using the Amersham cDNA synthesis system (47) . Complementary DNAs larger than 500 bp were selected by gel filtration, ligated to 1 ng Xgt11 arms (Promega Biotec, Madison, Wl), and packaged using the Gigapack Gold in vitro X DNA packaging kit (Stratagene, San Diego, CA). A total of 2.3 x 10 6 recombinant phage were obtained; of the total phage, 1 1 % were nonrecombinant. For the initial screening with affinity purified PAM antiserum, six 150-mm dishes were plated at a density of 63,000 recombinant phage per dish. To localize positive phage, isopropyl-/S-o-thiogalactopyranoside-coated nitrocellulose filters (Schleicher & Schuell, Keene, NH) were applied for 8 h, washed for 3 x 10 min at room temperature in TBS (50 mM Tris HCI, 150 HIM NaCI, pH 7.5) and blocked for 1 h at room temperature in TBS containing 0.1 mg/ml BSA (TBS/ BSA) and 0.1% Tween-20. Primary antibody was diluted in TBS/BSA plus Tween-20 and allowed to incubate overnight at 4 C or for 4 h at room temperature. Filters were then washed 3 x 10 min at room temperature in TBS/BSA plus Tween-20 and [ 125 l]labeled Protein A (10 s cf>m/ml) was added in TBS/BSA for 2-4 h at room temperaure. Filters were washed for 10 min at room temperature in TBS/BSA, for 2 x 10 min in TBS/BSA containing 0.1 % NP-40, for 10 min in TBS/ BSA before visualization by autoradiography at -7 0 C with an intensifying screen. In the initial screen with affinity purified PAM antiserum 36,18 positive plaques were identified. Upon rescreening, only six remained positive; the four phage giving the strongest signals (XPAM-1, 2, 3, and 5) were plaque purified and further characterized. In the second round of screening the library, nick translated 0.4 kb and 0.7 kb XPAM-1 cDNA were used to screen replica nitrocellulose lifts prepared from four 150-mm plates (90,000 recombinant phage/ plate); plaques hybridizing with either or both cDNA probe were identified and a subset were plaque purified, characterized by Southern blot analysis, and a likely full length phage (XPAM-6) was further characterized.
Cloning and cDNA Sequence Analysis
The EcoRI fragments of XPAM-1, -5, and -6 were subcloned into Bluescript (Stratagene) and sequenced by the dideoxychain termination method (18) (19) (20) . Single stranded sequencing was performed as described by Stratagene. Double stranded sequencing was performed as described by New England Biolabs (Beverly, MA). To sequence the 2.2-kb EcoRI fragment of XPAM-1, nested sets of deletions extending inwards from the 5'-and 3'-termini of the cDNA were generated with an Exolll/Mung Bean Nuclease kit from Stratagene. To sequence the 0.8-kb EcoRI fragment of XPAM-6, deletions with A/del and Nar\ were prepared. The EcoRI site separating the 0.8-and 0.7-kb fragments is in peptide HR6, and both EcoRI fragments hybridized with OLIGO6. The sequence across the EcoRI site separating the 0.7-and 2.2-kb fragments was obtained by subcloning the appropriate Sspl-Xbal fragment and using a synthetic oligonucleotide primer. Synthetic oligonucleotide primers or deletions using unique restriction sites were used to direct sequencing to a particular region of the molecule.
Fusion Protein Antibodies
from the wild type and XPAM-1 samples were analyzed on slab gels and visualized with Coomassie brilliant blue. The fractions from the XPAM-1 sample containing proteins ranging in size from myosin to /3-galactosidase were pooled and used for immunization of rabbits. Three female New Zealand white rabbits (2 kg) were immunized with one-sixth of the fusion protein (0.5 A 280 U each) from a 50-ml culture emulsified in Freund's complete adjuvant. Rabbits were given five booster injections of the same amount of fusion protein in incomplete Freund's adjuvant at intervals of 2-4 weeks.
The ability of various antisera to recognize PAM was assayed by cross-linking the immunoglobulin fraction to Protein A-Sepharose (Pharmacia, Piscataway, NJ) as described (16) . In addition to assaying the ability of the antibody resin to remove PAM activity from solution (16) , the appearance of resin-bound PAM activity was determined. Resin prepared from Ab 46 had a significant amount of PAM activity (0.15 pmol/h for 10 n\ packed resin); this PAM activity is thought to be due to circulating (15) rabbit PAM bound to the immunoglobulin. In order to reduce this background PAM activity, immunoglobulins from rabbit Ab 46 were precipitated with ammonium sulfate, dialyzed into 3 M KSCN, 0.1 M Tris HCI, pH 7.2, and fractionated on a Sephacryl S-300 column (1 x 50 cm) in the same buffer. The fractions containing proteins larger than 80,000 daltons were dialyzed into 50 mwi NaTES, pH 7.4, and linked to protein A-Sepharose (16) . After this treatment, resin prepared from Ab 46 contained less than 1 % as much PAM activity as before the treatment. The preimmune serum and Ab 36 were not KSCN-treated before linking to protein A-Sepharose; the Ab 36 resin exhibited PAM activity.
Northern Blot Analyses of Various Bovine Tissues
Total RNA was prepared by the method of Chirgwin et al. (46) . Duplicate aliquots of total RNA were fractionated on a 1 % agarose gel containing 2.2 M formaldehyde, transferred to Nytran (Schleicher & Schuell), and hybridized with the nicktranslated probes. Blots were prehybridized for 2-4 h at 42 C in 5x SSC (20x SSC is 3.0 M NaCI, 0.3 M Na citrate, pH 7.0), 4x Denhardt's (50x Denhardt's is 1% Ficoll, 1 % polyvinylpyrrolidone, 1% BSA in water), 50% deionized formamide, 20 mM Na phosphate, pH 6.8, 0.1% SDS, 0.1 mg/ml sonicated carrier herring sperm DNA. Hybridization was carried out by adding boiled nick-translated probe (~10 6 cpm/ml; SA, 0.5 to 2 x 10 9 cpm/^g DNA) and continuing the incubation at 42 C for 16-24 h. Filters were washed 2 x 30 min in 2x SSC, 0.1% SDS at room temperature, and 2 x 30 min in 0.1 x SSC, 0.1% SDS at 50 C before autoradiography at -7 0 C with an intensifying screen. Probes were stripped off by incubation in 50% formamide, 1 x SSC at 70 C for 60 min, and the blot was reprobed with a second probe. Sample application position is marked by a bar and the standards are shown at the left. For molecular weight determination, the 18 S and 28 S ribosomal RNAs were visualized with acridine orange and an RNA ladder (Bethesda Research Laboratories, Gaithersburg, MD) fractionated in an adjacent lane was visualized by hybridization to nicktranslated wild type XDNA.
Determination of pro-ACTH/Endorphin-Related mRNA and Peptides
For production of fusion protein antibody, cell pellets from 50 ml cultures of Escherichia coli strain CAG456 cells infected with wild type Xgt11 or XPAM-1 were lysed by freeze-thawing and sonication in 1.5 ml 100 mM Na TES, pH 7.4, 10 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and centrifuged at 10,000 x g for 10 min; very little fusion protein appeared in the soluble fraction. The cell pellets were dissolved by boiling in 2.0 ml SDS sample buffer (17) and were individually applied to a column of Sephacryl S-300 SF (1 x 53 cm) equilibrated and eluted with 2x running gel buffer. Aliquots of fractions AtT-20/D-16v mouse corticotropic tumor cells were grown as described (14) . Parallel wells were harvested in guanidine thiocyanate for extraction of RNA (46) or in 50% acetic acid for RIA of pro-ACTH/endorphin-derived peptides (48) . Secretory rates (% cell hormone content secreted/hour) were determined by RIA of 16 K fragment in spent medium and cell extracts (48) . Equal aliquots of total RNA were fractionated on formaldehyde agarose gels as described above. Levels of pro-ACTH/endorphin mRNA were determined using nick-translated pMKSU probe (49) . 
